Fracture prevention in postmenopausal women

Clin Evid. 2006 Jun:(15):1543-60.

Authors

Leif Mosekilde¹, Peter Vestergaard, Bente Langdahl

Affiliation

¹ Faculty of Health sciences, University of Aarhus and Dept of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus C, Denmark.

PMID: 16973058

No abstract available

Publication types

Review

MeSH terms

Aged
Alendronate / therapeutic use
Bone Density Conservation Agents / therapeutic use
Calcitonin / therapeutic use
Calcium / therapeutic use
Clodronic Acid / therapeutic use
Diphosphonates / therapeutic use
Etidronic Acid / analogs & derivatives
Etidronic Acid / therapeutic use
Female
Fractures, Spontaneous / prevention & control
Hormone Replacement Therapy
Humans
Ibandronic Acid
Osteoporosis, Postmenopausal / prevention & control*
Pamidronate
Parathyroid Hormone / therapeutic use
Risedronic Acid
Selective Estrogen Receptor Modulators / therapeutic use
Vitamin D / therapeutic use

Substances

Bone Density Conservation Agents
Diphosphonates
Parathyroid Hormone
Selective Estrogen Receptor Modulators
Clodronic Acid
Vitamin D
Calcitonin
Risedronic Acid
Etidronic Acid
Pamidronate
Calcium
Ibandronic Acid
Alendronate